CRNX
Price
$52.99
Change
-$2.38 (-4.30%)
Updated
Dec 18, 04:10 PM (EDT)
90 days until earnings call
OLMA
Price
$5.74
Change
-$0.40 (-6.51%)
Updated
Dec 18, 04:26 PM (EDT)
75 days until earnings call
Ad is loading...

CRNX vs OLMA

Header iconCRNX vs OLMA Comparison
Open Charts CRNX vs OLMABanner chart's image
Crinetics Pharmaceuticals
Price$52.99
Change-$2.38 (-4.30%)
Volume$800
CapitalizationN/A
Olema Pharmaceuticals
Price$5.74
Change-$0.40 (-6.51%)
Volume$504
CapitalizationN/A
CRNX vs OLMA Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. OLMA commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Buy and OLMA is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (CRNX: $55.37 vs. OLMA: $6.14)
Brand notoriety: CRNX and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 154% vs. OLMA: 200%
Market capitalization -- CRNX: $5.13B vs. OLMA: $453.17M
CRNX [@Biotechnology] is valued at $5.13B. OLMA’s [@Biotechnology] market capitalization is $453.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 1 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 1 green, 4 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, CRNX is a better buy in the long-term than OLMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while OLMA’s TA Score has 4 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 6 bearish.
  • OLMA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, OLMA is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а -3.15% price change this week, while OLMA (@Biotechnology) price change was -36.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 18, 2025.

OLMA is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($5.14B) has a higher market cap than OLMA($453M). CRNX YTD gains are higher at: 55.621 vs. OLMA (-56.237). OLMA has higher annual earnings (EBITDA): -135.54M vs. CRNX (-304.51M). CRNX has more cash in the bank: 863M vs. OLMA (215M). OLMA has less debt than CRNX: OLMA (1.7M) vs CRNX (52.5M). CRNX has higher revenues than OLMA: CRNX (1.04M) vs OLMA (0).
CRNXOLMACRNX / OLMA
Capitalization5.14B453M1,134%
EBITDA-304.51M-135.54M225%
Gain YTD55.621-56.237-99%
P/E RatioN/AN/A-
Revenue1.04M0-
Total Cash863M215M401%
Total Debt52.5M1.7M3,090%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
9
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXOLMA
RSI
ODDS (%)
Bearish Trend 7 days ago
86%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BPTRX230.561.21
+0.53%
Baron Partners Retail
JINTX31.97-0.11
-0.34%
Johnson International
AUIZX32.86-0.15
-0.45%
AB Equity Income Z
JSGRX30.28-0.16
-0.53%
JHancock U.S. Growth R2
RMBNX44.45-1.53
-3.33%
RMB Mendon Financial Services C

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XENE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+1.35%
XENE - CRNX
47%
Loosely correlated
-0.07%
ARWR - CRNX
47%
Loosely correlated
-0.45%
PGEN - CRNX
44%
Loosely correlated
+2.46%
RARE - CRNX
44%
Loosely correlated
-0.99%
ELVN - CRNX
44%
Loosely correlated
+3.48%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with RCKT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
-4.66%
RCKT - OLMA
46%
Loosely correlated
+1.36%
AGIO - OLMA
42%
Loosely correlated
-1.71%
CRNX - OLMA
42%
Loosely correlated
+1.35%
IDYA - OLMA
41%
Loosely correlated
+1.07%
PGEN - OLMA
41%
Loosely correlated
+2.46%
More